Personalized Ophthalmology Therapies Market Report 2026
Download Free Sample Buy Now
Personalized Ophthalmology Therapies Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Personalized Ophthalmology Therapies Market Report 2026

Global Outlook – By Therapy Type (Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types), By Indication (Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications), By End User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Personalized Ophthalmology Therapies Market Overview

• Personalized Ophthalmology Therapies market size has reached to $3.23 billion in 2025

• Expected to grow to $6.22 billion in 2030 at a compound annual growth rate (CAGR) of 14%

• Growth Driver: Rising Prevalence Of Chronic Vision Disorders Driving The Growth Of The Market Due To Increasing Diabetes Cases And Associated Eye Complications

• Market Trend: Advancements In Single-Dose Intravitreal Gene Therapies Reducing Treatment Burden And Enhancing Long-Term Efficacy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Ophthalmology Therapies Market?

Personalized ophthalmology therapies refer to customized treatment approaches for eye diseases and vision disorders that are tailored to an individual patient’s unique genetic profile, molecular characteristics, lifestyle, and clinical condition. These therapies leverage advances in genomics, biomarker analysis, imaging, and precision medicine to optimize drug selection, dosage, or surgical intervention for conditions such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and inherited retinal diseases.

The main types of personalized ophthalmology therapies include gene therapy, cell therapy, pharmacogenomics, targeted drug delivery, and others. Gene therapy in ophthalmology involves introducing or altering genetic material within a patient's cells to treat eye diseases caused by genetic mutations. It is used for various indications such as age-related macular degeneration, diabetic retinopathy, glaucoma, retinitis pigmentosa, and others by several end users, including hospitals, specialty clinics, research institutes, and others.

Personalized Ophthalmology Therapies Market Global Report 2026 Market Report bar graph

What Is The Personalized Ophthalmology Therapies Market Size and Share 2026?

The personalized ophthalmology therapies market size has grown rapidly in recent years. It will grow from $3.23 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to advancements in retinal disease research, increasing prevalence of chronic eye disorders, expansion of ophthalmology specialty clinics, improvements in ocular imaging technologies, growth in clinical trial activity for eye diseases.

What Is The Personalized Ophthalmology Therapies Market Growth Forecast?

The personalized ophthalmology therapies market size is expected to see rapid growth in the next few years. It will grow to $6.22 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing approvals of gene and cell therapies, rising investments in precision ophthalmology research, expansion of personalized treatment protocols, growing adoption of advanced drug delivery platforms, increasing demand for long-term vision preservation solutions. Major trends in the forecast period include increasing development of gene-based ophthalmic therapies, rising adoption of biomarker-guided treatment approaches, growing use of advanced retinal imaging for therapy selection, expansion of targeted drug delivery systems, enhanced focus on personalized disease management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Personalized Ophthalmology Therapies Market Segmentation

1) By Therapy Type: Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types

2) By Indication: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications

3) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing

2) By Cell Therapy: Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

3) By Pharmacogenomics: Drug Response Testing, Genetic Biomarker-Based Therapy, Personalized Drug Dosing

4) By Targeted Drug Delivery: Nanoparticle-Based Delivery, Liposomal Drug Delivery, Hydrogel-Based Delivery Systems

5) By Other Therapy Types: RNA-Based Therapy, Antisense Oligonucleotide Therapy, Peptide-Based Therapy

What Is The Driver Of The Personalized Ophthalmology Therapies Market?

The growing prevalence of chronic vision disorders is expected to propel the growth of the personalized ophthalmology therapies market going forward. Chronic vision disorders are persistent eye diseases that progressively impair vision and often require ongoing management over an extended period. Chronic vision disorders are rising due to the increasing prevalence of diabetes worldwide, which leads to complications such as diabetic retinopathy that progressively damage the eyes over time. Personalized ophthalmology therapies benefit chronic vision disorders by creating treatment plans tailored to an individual’s unique genetic and molecular profile, which enhances treatment effectiveness and helps slow the progression of the disease. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, if effective measures are not implemented, cases of diabetic retinopathy are projected to rise by 72%, while cataract cases are expected to grow by 87% by 2050. Therefore, the growing prevalence of chronic vision disorders is driving the growth of the personalized ophthalmology therapies industry.

Key Players In The Global Personalized Ophthalmology Therapies Market

Major companies operating in the personalized ophthalmology therapies market are Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.

Global Personalized Ophthalmology Therapies Market Trends and Insights

Major companies operating in the personalized ophthalmology therapies market are focusing on developing advanced solutions, such as one-time intravitreal gene therapies, to minimize patient burden and lower the risk of complications associated with multiple injections. One-time intravitreal gene therapies involve a single injection into the eye’s vitreous cavity to deliver genetic material that addresses or modifies underlying eye disorders, offering lasting treatment effects. For instance, in July 2025, Sanofi, a France-based pharmaceutical and healthcare company, announced the US Food and Drug Administration (FDA) has approved fast track designation for SAR446597. It is a single-dose intravitreal gene therapy designed to treat geographic atrophy (GA) caused by age-related macular degeneration (AMD). It has received fast-track designation to speed up development and regulatory review for serious conditions with unmet needs. The therapy introduces genetic material encoding two antibody fragments that block C1s in the classical complement pathway and factor Bb in the alternative pathway. This dual-action mechanism aims to provide long-lasting complement suppression in the retina, targeting the disease process while minimizing the need for repeated injections.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Personalized Ophthalmology Therapies Market?

In December 2024, EssilorLuxottica S.A., a France-based healthcare company, acquired Espansione Group for an undisclosed amount. With this acquisition, EssilorLuxottica aimed to expand its med-tech portfolio and strengthen its offering of advanced vision-care instruments and certified medical technologies. Espansione Group S.p.A. is an Italy-based med-tech company that specializes in providing personalized ophthalmology therapies.

Regional Outlook

North America was the largest region in the personalized ophthalmology therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Ophthalmology Therapies Market?

The personalized ophthalmology therapies market includes revenues earned by entities by providing services such as molecular profiling, biomarker identification, patient data integration services, and disease risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Ophthalmology Therapies Market Report 2026?

The personalized ophthalmology therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized ophthalmology therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Personalized Ophthalmology Therapies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.69 billion
Revenue Forecast In 2035 $6.22 billion
Growth Rate CAGR of 14.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy Type, Indication, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Personalized Ophthalmology Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Personalized Ophthalmology Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Personalized Ophthalmology Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Personalized Ophthalmology Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Development Of Gene-Based Ophthalmic Therapies

4.2.2 Rising Adoption Of Biomarker-Guided Treatment Approaches

4.2.3 Growing Use Of Advanced Retinal Imaging For Therapy Selection

4.2.4 Expansion Of Targeted Drug Delivery Systems

4.2.5 Enhanced Focus On Personalized Disease Management

5. Personalized Ophthalmology Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Ophthalmology Clinics

5.3 Research Institutes

5.4 Academic Medical Centers

5.5 Ophthalmic Pharmaceutical Companies

6. Personalized Ophthalmology Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Ophthalmology Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Personalized Ophthalmology Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Personalized Ophthalmology Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Personalized Ophthalmology Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Personalized Ophthalmology Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Ophthalmology Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Ophthalmology Therapies Market Segmentation

9.1. Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types

9.2. Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications

9.3. Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.4. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing

9.5. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

9.6. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Response Testing, Genetic Biomarker-Based Therapy, Personalized Drug Dosing

9.7. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nanoparticle-Based Delivery, Liposomal Drug Delivery, Hydrogel-Based Delivery Systems

9.8. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

RNA-Based Therapy, Antisense Oligonucleotide Therapy, Peptide-Based Therapy

10. Personalized Ophthalmology Therapies Market Regional And Country Analysis

10.1. Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Ophthalmology Therapies Market

11.1. Asia-Pacific Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Ophthalmology Therapies Market

12.1. China Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Ophthalmology Therapies Market

13.1. India Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Ophthalmology Therapies Market

14.1. Japan Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Ophthalmology Therapies Market

15.1. Australia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Ophthalmology Therapies Market

16.1. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Ophthalmology Therapies Market

17.1. South Korea Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Ophthalmology Therapies Market

18.1. Taiwan Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Ophthalmology Therapies Market

19.1. South East Asia Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Ophthalmology Therapies Market

20.1. Western Europe Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Ophthalmology Therapies Market

21.1. UK Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Ophthalmology Therapies Market

22.1. Germany Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Ophthalmology Therapies Market

23.1. France Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Ophthalmology Therapies Market

24.1. Italy Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Ophthalmology Therapies Market

25.1. Spain Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Ophthalmology Therapies Market

26.1. Eastern Europe Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Ophthalmology Therapies Market

27.1. Russia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Ophthalmology Therapies Market

28.1. North America Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Ophthalmology Therapies Market

29.1. USA Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Ophthalmology Therapies Market

30.1. Canada Personalized Ophthalmology Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Ophthalmology Therapies Market

31.1. South America Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Ophthalmology Therapies Market

32.1. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Ophthalmology Therapies Market

33.1. Middle East Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Ophthalmology Therapies Market

34.1. Africa Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Ophthalmology Therapies Market Regulatory and Investment Landscape

36. Personalized Ophthalmology Therapies Market Competitive Landscape And Company Profiles

36.1. Personalized Ophthalmology Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Personalized Ophthalmology Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Personalized Ophthalmology Therapies Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Ophthalmology Therapies Market Other Major And Innovative Companies

Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc.

38. Global Personalized Ophthalmology Therapies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Ophthalmology Therapies Market

40. Personalized Ophthalmology Therapies Market High Potential Countries, Segments and Strategies

40.1 Personalized Ophthalmology Therapies Market In 2030 - Countries Offering Most New Opportunities

40.2 Personalized Ophthalmology Therapies Market In 2030 - Segments Offering Most New Opportunities

40.3 Personalized Ophthalmology Therapies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Personalized Ophthalmology Therapies Market, Overview Of Key Products - Product Examples
  • Table 2: Global Personalized Ophthalmology Therapies Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Personalized Ophthalmology Therapies Market, Supply Chain Analysis
  • Table 4: Global Personalized Ophthalmology Therapies Market, Major Raw Material Providers
  • Table 5: Global Personalized Ophthalmology Therapies Market, Major Resource Providers
  • Table 6: Global Personalized Ophthalmology Therapies Market, Major Manufacturers (Suppliers)
  • Table 7: Global Personalized Ophthalmology Therapies Market, Major Distributors And Channel Partners
  • Table 8: Global Personalized Ophthalmology Therapies Market, Key Technologies & Future Trends
  • Table 9: Global Personalized Ophthalmology Therapies Market, Major Trends
  • Table 10: Global Personalized Ophthalmology Therapies Market, Major End Users
  • Table 11: Global Personalized Ophthalmology Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Personalized Ophthalmology Therapies Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Personalized Ophthalmology Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Personalized Ophthalmology Therapies Market - TAM, US$ Billion, 2025
  • Table 15: Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Personalized Ophthalmology Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Personalized Ophthalmology Therapies Market - Company Scoring Matrix
  • Table 99: Roche Holding AG Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 102: Alcon Inc. Financial Performance
  • Table 103: Genentech Inc. Financial Performance
  • Table 104: Global Personalized Ophthalmology Therapies Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Personalized Ophthalmology Therapies Market, Competitive Dashboard
  • Table 106: Global Personalized Ophthalmology Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Table 108: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 109: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Personalized Ophthalmology Therapies Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Personalized Ophthalmology Therapies Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Personalized Ophthalmology Therapies Market, Supply Chain Analysis
  • Figure 4: Global Personalized Ophthalmology Therapies Market, Major Raw Material Providers
  • Figure 5: Global Personalized Ophthalmology Therapies Market, Major Resource Providers
  • Figure 6: Global Personalized Ophthalmology Therapies Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Personalized Ophthalmology Therapies Market, Major Distributors And Channel Partners
  • Figure 8: Global Personalized Ophthalmology Therapies Market, Key Technologies & Future Trends
  • Figure 9: Global Personalized Ophthalmology Therapies Market, Major Trends
  • Figure 10: Global Personalized Ophthalmology Therapies Market, Major End Users
  • Figure 11: Global Personalized Ophthalmology Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Personalized Ophthalmology Therapies Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Personalized Ophthalmology Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Personalized Ophthalmology Therapies Market - TAM, US$ Billion, 2025
  • Figure 15: Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Personalized Ophthalmology Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Personalized Ophthalmology Therapies Market - Company Scoring Matrix
  • Figure 99: Roche Holding AG Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 102: Alcon Inc. Financial Performance
  • Figure 103: Genentech Inc. Financial Performance
  • Figure 104: Global Personalized Ophthalmology Therapies Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Personalized Ophthalmology Therapies Market, Competitive Dashboard
  • Figure 106: Global Personalized Ophthalmology Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Figure 108: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 109: Global, Personalized Ophthalmology Therapies Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Ophthalmic Drugs Market Report 2026 - Global Outlook – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Gla...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectab...

Ophthalmic Devices Market Report 2026 - Global Outlook – By Device (Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmi...

Ocular Inflammation Treatment Market Report 2026 - Global Outlook – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode Of Operation (Injectables, O...

Ocular Drug Delivery Market Report 2026 - Global Outlook – By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies), By Formulati...

Ophthalmic Medical Lasers Market Report 2026 - Global Outlook – By Product (Diode Lasers, Femtosecond Lasers, Excimer Lasers, Tissue Treatment Lasers, ND (Yag Lasers, Other Products), By Application (Refractive Error Cor...

Ophthalmic Eye Dropper Market Report 2026 - Global Outlook – By Eye Dropper (Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper), By Drug Type (Prescription Drugs, Over-The-Co...

Ophthalmology Drugs Market 2023 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies or Drug Stores, Other Distribution Channe...

Frequently Asked Questions

The Personalized Ophthalmology Therapies market was valued at $3.23 billion in 2025, increased to $3.69 billion in 2026, and is projected to reach $6.22 billion by 2030.

The global Personalized Ophthalmology Therapies market is expected to grow at a CAGR of 14.0% from 2026 to 2035 to reach $6.22 billion by 2035.

Some Key Players in the Personalized Ophthalmology Therapies market Include, Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics. .

Major trend in this market includes: Advancements In Single-Dose Intravitreal Gene Therapies Reducing Treatment Burden And Enhancing Long-Term Efficacy. For further insights on this market. request a sample here

North America was the largest region in the personalized ophthalmology therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized ophthalmology therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us